AstraZeneca unveils drug to treat mutating breast cancer before it starts to grow—Professor @helink.bsky.social chief executive of the Institute of Cancer Research, said the results… www.ft.com/content/9c3b... @hannahkuchler.bsky.social @financialtimes.com
Congratulations to the MSK-IMPACT team MSK for receiving the @theaacr.bsky.social Team Science Award.
The team is recognized for its pivotal advances in clinical genomic sequencing that have transformed oncology practice, clinical trials, and cancer discovery research. Learn more: bit.ly/4jJMaOu
Well done to all our fundraisers and runners who took part of the #LondonMarathon yesterday for the ICR!
Thank you so much for your support – it's a great motivator for all of us working in research to make the discoveries that defeat cancer.
....and to be followed by broad investment in science as the columnist suggests.
www.theguardian.com/commentisfre...
Compelling argument!
Compelling argument!
Science under attack: a growing list of statements from journals
@jama.com
jamanetwork.com/journals/jam...
@plos.org
theplosblog.plos.org/2025/02/plos...
@science.org
www.science.org/doi/10.1126/...
@nature.com
www.nature.com/articles/d41...
@embopress.org
www.embopress.org/doi/full/10....
The AACR is deeply concerned that the Administration’s recent actions are threatening NIH and its mission to accelerate progress for patients with cancer and other diseases that afflict millions of Americans. Read our statement: https://buff.ly/4gRXNB8
The ICR has played a crucial role in the development of the targeted drug #Olaparib.
Professor Kristian Helin, (@helink.bsky.social) - Chief Executive of the ICR, said: "I’m proud of the decades of research at the ICR that have underpinned this achievement."
Zuckerberg is less insecure than Musk, so he sometimes tries to come off as chastened and innocent. In fact, Zuckerberg has never retreated from his belief that he and his companies deserve the power they have and should mold the world to his vision of the greater good!"
Interesting analysis on Zuckerberg in The Guardian.
"He is not acting as a mercenary capitalist. He is acting as a megamaniacal ideologue, as usual. Zuckerberg’s self-regard is beyond limits. Perhaps only Musk, among his peers, has more self-regard.
www.theguardian.com/commentisfre...
Difficult not to be worried!
Washington Post Cartoonist Quits After Jeff Bezos Cartoon Is Killed www.nytimes.com/2025/01/03/b...
Entertaining - also if you are not into sports.
www.theguardian.com/sport/2024/d...
Make Britain Great Again: Interesting and relevant analysis - which, although not surprising, should influence decision making in the UK (government).
www.theguardian.com/commentisfre...
👋We're looking for a #Software #Engineer to join our Centre, to develop and maintain a patient app platform as part of a collaborative project.
Check out the job listing for more information jobs.icr.ac.uk/vacancies/10...
@icrlondon.bsky.social
Paul Nurse did not sign it.
See if this link works.
www.nytimes.com/interactive/...
Worth paying for!
Read the Letter From Nobel Laureates Urging That Mr. Kennedy Not be Confirmed www.nytimes.com/interactive/...
👋Hello to the #CancerResearch community on Bluesky. If you want to know more about #ConvergenceScience and how we bring researchers together from @imperialcollegeldn.bsky.social and @icrlondon.bsky.social check out our new website page 👇
www.convergencesciencecentre.ac.uk/about/our-mi...
🆕 Scientists have worked out a way to predict how long #ProstateCancer patients will respond to the PARP inhibitor drug olaparib, according to new research published in #CancerCell.
Read more ⤵️
www.icr.ac.uk/news-archive...
Registration now for the 2025 Cancer Genetics and Epigenetics GRC, a premier event for you to dive into groundbreaking research and network with leading experts in the field.
📅 Date: May 18-23, 2025
📍 Venue: Tuscany, Italy
🔗 Apply Now: www.grc.org/cancer-genet...
Follow the Institute of Cancer Research on our new Bluesky account. Moving from X -
@icrlondon.bsky.social
